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Abstract 
Background: The rates of readmission for serious cardiovascular events among patients 
admitted with a diagnosis of non-specific chest pain are unknown. 
Methods: A national retrospective cohort study in the United States was undertaken to 
evaluate the rates, trends and predictors of readmission for serious cardiovascular events 
(acute coronary syndrome (ACS), pulmonary embolism (PE) and aortic dissection (AD)) 
after an inpatient episode with a primary diagnosis of non-specific chest pain. 
Results: Among 1,172,430 patients with an index diagnosis of non-specific chest pain 
between 2010 and 2014, 2.4% were readmitted with an ACS, 0.4% with a PE and 0.06% with 
an AD within 6 months of discharge. Predictors of ACS readmissions were diabetes (OR 1.49 
95%CI 1.17-1.32), coronary artery disease (OR 2.29 95%CI 2.15-2.44), previous 
percutaneous coronary intervention (OR 1.65 95%CI 1.56-1.75), previous CABG (OR 1.52 
95%CI 1.43-1.61) and discharge against medical advice (OR 1.94 95%CI 1.78-2.12). Female 
patients (OR 0.82 95%CI 0.78-0.86) and patients in whom a coronary angiogram was 
undertaken (OR 0.48 95%CI 0.45-0.52) were less likely to be readmitted for ACS. For PE, 
predictors of readmission were pulmonary circulatory disorder (OR 2.20 95%CI 1.09-4.43), 
anemia (OR 1.62 95%CI 1.40-1.86) and cancer (OR 4.15 95%CI 3.43-5.02). Peripheral 
vascular disease (OR 8.63 95%CI 5.47-13.60), renal failure (OR 2.08 95%CI 1.34-3.24) were 
predictors of AD.  
Conclusions: Non-specific chest pain may not be a benign condition as readmissions for 
serious cardiovascular events occur in 3% of patients within 180 days. Research is needed to 
define measures that may mitigate readmissions among these patients. 
 
Keywords: chest pain; acute coronary syndrome; pulmonary embolism; aortic dissection 
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Introduction 
In the United States, 6 million patients present with chest pain to the emergency 
department (ED) each year, at an estimated cost of $8 billion.[1] These presentations account 
for approximately 5% of all ED visits; 65% of patients are subsequently admitted to the 
hospital, representing a quarter of all emergency medical admissions.[2]  An important group 
of these patients are those diagnosed with non-specific chest pain which was introduced in 
order to describe the subset of patient not explained by a coronary ischemic etiology.[3] This 
diagnosis of exclusion accounts for approximately 50% of chest pain related emergency 
department visits.[4] 
 The primary goal in the evaluation of patients with non-specific chest pain is to 
accurately identify patients with acute coronary syndrome (ACS) and other serious 
cardiovascular conditions.[5] Once serious causes of chest pain requiring immediate attention 
have been ruled out, it is generally safe to discharge patients and investigate those with 
suspected coronary artery disease as out-patients.[4] Other potentially life-threatening 
conditions can also present with symptoms of non-specific chest pain including pulmonary 
embolism[6] and aortic dissection.[7] However, diagnostic work-ups may not be 100% 
sensitive or specific, and important diagnoses may have gone undetected on the initial 
admission. The literature on non-specific chest pain is limited and there are no prior national 
studies. 
The aim of this study is to evaluate the rates of readmission for ACS, pulmonary 
embolism and aortic dissection among patients in an unselected national cohort previously 
diagnosed with non-specific chest pain during an admission in the prior 6 months. 
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Methods 
The Nationwide Readmissions Database (NRD) contains national hospitalization and 
rehospitalization data for patients of all ages within the United States, which is produced by 
the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and 
Quality. The NRD collects inpatient data and the current analysis does not contain 
information about emergency department discharges. The NRD contains a de-identified 
unique patient linkage number, which allows for the determination of readmissions by 
tracking of patients across hospitals within a calendar year. The annualized nature of NRD 
means that tracking patients across calendar years is not possible.  
We included patients, aged 18 years or older, with a primary diagnosis of non-specific 
chest pain who were discharged between 2010 and 2014 with at least 180-day follow up. 
Non-specific chest pain was defined by the International Statistical Classification of Disease 
and Related Health Problems (ICD) 9 codes 78650 (CHEST PAIN, UNSPECIFIED), 78651 
(PRECORDIAL PAIN), 78652 (PLEURITIC PAIN) and 78659 (OTHER CHEST PAIN). 
Patients were excluded if they died during index admission, had index admissions with 
percutaneous coronary intervention (PCI), discharged during the months July to December 
(thus lacking 180 days of follow up) or had a first readmission that was classified as elective. 
We collected data on patient demographics, comorbidities, hospital characteristics and tests 
from codes in the NRD codes, ICD-9 codes and Elixhauser comorbidity codes as described in 
Supplemental Data 1. 
The primary outcome of the study was unplanned readmission within 180 days for a 
serious cardiovascular event defined by a primary diagnosis of ACS (4100*–4109* 4111*), 
pulmonary embolus (4151*) or aortic dissection (4410*). We also determined the cost of the 
readmission, length of stay and rate of death during readmission. 
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Statistical analysis was performed on Stata 14.0 (College Station, TX). Estimated 
population sizes were determined by using the survey estimation command in Stata (SVY) 
with the NRD discharge weight (DISCWT). Estimated crude number of admissions for non-
specific chest pain and readmission rate for each serious cardiovascular disease was plotted 
over the years of the study. Time to readmission for serious cardiovascular causes was 
displayed with histograms. Descriptive statistics are presented according to the presence or 
absence of readmission for a serious cardiovascular cause and receipt of each group of 
investigations.  Multiple logistic regressions were used to investigate the associations of all 
the variables previously described to the readmission for each serious cardiovascular disease 
and the variables described and their association with the receipt of investigation. For the 
purposes of statistical analyses for the group of patients where investigations were performed, 
we defined any test as receipt of test for ACS, pulmonary embolism and aortic dissection. 
The effect of investigations on each serious cardiovascular cause for readmission was 
explored graphically and subgroup analysis based on receipt of CT thorax and radioisotope 
scan was performed.  
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Results 
 There were 2,369,384 patients admitted with an index diagnosis of non-specific chest 
pain and, after removal of patients according to the exclusion criteria, 1,172,430 patients 
were included in the analysis (Supplementary Figure 1). The number of admissions with a 
primary diagnosis of non-specific chest pain decreased over time from 130,604 in 2010 to 
75,906 in 2014 (Figure 1). During this time there was a modest rise in the proportion of 
patients receiving in-patient investigation from 20.5% to 21.2% (Supplementary Figure 2). 
Among the patients with a diagnosis of non-specific chest pain, 2.4% (n=27,930) 
were readmitted with ACS, 0.4% (n=4,751) with a pulmonary embolus and 0.06% (n=566) 
with an aortic dissection within 6 months of discharge with the time to readmission (up to 
180 days) shown in Supplementary Figure 3. The daily rate of readmission for ACS, 
pulmonary embolus and aortic dissection was highest during the first few days after discharge 
with a diagnosis of non-specific chest pain, with a progressive decline in readmissions up to 
50 days following discharge. 
Patient characteristics according to readmission status are shown in Table 1. Patients 
readmitted with a serious cardiovascular event were older compared to those not readmitted 
for serious cardiovascular event (64.4, 61.3 and 64.1 for ACS, pulmonary embolism and 
aortic dissection, respectively compared to 60.0 years with no readmission). The majority of 
those who were readmitted with pulmonary embolus were female (55.7%), where the 
majority of those readmitted for ACS or aortic dissection were male (55.1% and 54.4%, 
respectively). Medicare coverage was more prevalent among those readmitted for serious 
cardiovascular events (59.6% for ACS, 55.3% for pulmonary embolism and 56.9% for aortic 
dissection compared to 42.7% for non-Medicare patients) compared to those not readmitted 
for a serious cardiovascular cause. The cost for the first index chest pain admission in patients 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
later diagnosed with pulmonary embolism ($6,276) and aortic dissection ($6,616) was greater 
than patients with no readmission ($5,288) or readmission for ACS ($5,299).  
The outcomes for patients with serious cause for readmissions are shown in Table 1. 
The cost of the readmission was $17,708 for ACS, $18,412 for pulmonary embolism and 
$31,270 for aortic. The length of stay for readmission was 5.4 days, 8.6 days and 8.7 days 
and the mortality rate was 5.2%, 6.7% and 10.9% for ACS, pulmonary embolism and aortic 
dissection, respectively. 
The multivariable adjusted predictors of readmission for serious cardiovascular events 
are shown in Table 2. Predictors of ACS readmissions included diabetes (OR 1.49 95%CI 
1.17-1.32), coronary artery disease (OR 2.29 95%CI 2.15-2.44), previous PCI (OR 1.65 
95%CI 1.56-1.75), previous CABG (OR 1.52 95%CI 1.43-1.61) and discharge against 
medical advice (OR 1.94 95%CI 1.78-2.12). Female patients (OR 0.82 95%CI 0.78-0.86) and 
patients who received a coronary angiogram (OR 0.48 95%CI 0.45-0.52) were least likely to 
be readmitted for ACS. For pulmonary embolus, independent predictors of readmission were 
pulmonary circulatory disorder (OR 2.20 95%CI 1.09-4.43), anemia (OR 1.62 95%CI 1.40-
1.86) and cancer (OR 4.15 95%CI 3.43-5.02). Peripheral vascular disease (OR 8.63 95%CI 
5.47-13.60) and renal failure (OR 2.08 95%CI 1.34-3.24) were independently associated with 
aortic dissection. Patients who had received a CT thorax had significantly greater odds of 
readmissions for pulmonary embolus (OR 1.78 95%CI 1.39-2.29) and aortic dissection (OR 
2.25 95%CI 1.22-4.91) compared to patients who did not receive a CT thorax. 
Differences in characteristics according to receipt of coronary angiography at index 
admission was greater among smokers (36.1% vs 29.2%), patients with dyslipidemia (60.7% 
vs 49.0%) and patients a prior diagnosis of coronary artery disease (44.9% vs 31.2%) 
(Supplementary Table 1). Among patients with coronary angiogram 53.9% were women 
whilst the proportion of women was 55.1% among those without coronary angiogram. Tests 
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for pulmonary embolism were more commonly undertaken in patients at teaching hospitals 
(62.0% vs 44.0%) while tests for aortic dissection were more commonly performed in 
patients with peripheral vascular disease (10.3% vs 5.0%) admitted to teaching hospitals 
(56.5% vs 44.4%).  
Independent predictors for coronary angiography at index admission included a 
previous diagnosis of coronary artery disease (OR 2.40 95%CI 2.31-2.48) and large hospital-
bed number (OR 2.01 95%CI 1.75-2.31) (Table 3).  Other factors associated with a coronary 
angiogram included a history of smoking (OR 1.28 95%CI 1.24-1.31), dyslipidemia (OR 1.45 
95%CI 1.41-1.48), obesity (1.42 95%CI 1.38-1.46) and private healthcare insurance (OR 1.20 
95%CI 1.16-1.24). Patients from the highest income group were more likely to receive tests 
for pulmonary embolus and aortic dissection, (OR 2.63 95%CI 2.20-3.16 and OR 1.53 
95%CI 1.31-1.80, respectively) as were patients admitted to large hospital-bed number (OR 
1.42 95%CI 1.05-1.91 and OR 1.57 95%CI 1.26-1.95, respectively) and teaching hospitals 
(OR 1.94 95%CI 1.58-2.38 and OR 1.57 95%CI 1.36-1.83, respectively).  Patients with 
peripheral vascular disease and cancer were more likely to receive tests for pulmonary 
embolus and aortic dissection (OR 1.32 95%CI 1.22-1.43 and OR 2.64 95%CI 2.44-2.87 and 
OR 1.34 95%CI 1.20-1.49 and OR 1.52 95%CI 1.34-1.73, respectively). 
The rate of readmission for ACS in patients who received a coronary angiogram 
during index admission was 1.34% compared to 2.64% among patients who did not receive 
an angiogram during their index admission (Supplementary Figure 4). Patients who were 
tested for pulmonary embolism had a similar rate of readmission for pulmonary embolism 
compared to those who were not tested (0.43% vs 0.41%). There were slightly more 
readmissions for aortic dissection among patients who had a test for aortic dissection (0.09% 
vs 0.05%) compared to no test. The effect of investigations during index admission on the 
timing of readmissions for serious cardiovascular causes is shown in Supplementary Figure 5. 
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Receipt of any investigation significantly reduced events at all time points after discharge. 
Patients who received CT thorax and radioisotope scans had fewer readmission for ACS but 
more readmissions for aortic dissection (Supplementary Table 2). Patients with CT thorax 
had greater rate of readmission for pulmonary embolism but there were fewer readmissions 
for pulmonary embolism among patients with radioisotope scans. 
In our study cohort, we estimate that there were approximately 5,586 ACS 
admissions, 950 pulmonary embolism admissions and 113 aortic dissection admissions 
between the years of 2010 and 2014 following a diagnosis of non-specific chest pain during 
the index admission representing approximately $99 million, $17 million and $3.5 million 
dollars of healthcare expenditure respectively. 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
Discussion 
Our outcome analysis of a national cohort of patients with a diagnosis of nonspecific 
chest pain is not benign as readmission for serious cardiovascular events occur in up to 1 in 
30 of patients (primarily due to ACS) within a period of 6 months. The daily readmissions for 
serious cardiovascular events appear to be greatest shortly after discharge, peaking at 4 days 
for ACS and pulmonary embolism and 6 days for aortic dissection.  This suggests that some 
of these diagnoses may have been responsible for the initial admission. While receipt of an 
investigation as an inpatient, particularly a coronary angiogram, is associated with fewer 
readmissions, patients still return with serious cardiovascular events.   The mortality rate for 
readmissions for ACS, pulmonary embolus and aortic dissection was 5.2%, 6.7% and 10.9%, 
respectively and the estimated cost of $120 million between 2010 to 2014 (ACS $17,708, PE 
$18,412 and aortic dissection is $31,270 per readmission). Strong predictors of ACS 
readmissions were diabetes, coronary artery disease, previous PCI, previous CABG and 
discharge against medical advice. For pulmonary embolus these included pulmonary 
circulatory disorder, anemia, cancer and receipt of CT thorax.  Peripheral vascular disease, 
renal failure and receipt of a CT thorax were strong predictors of aortic dissection. 
Furthermore, we observed clear differences in utilization of investigations, particularly at the 
institutional level, with differences observed by teaching hospital status and hospital-bed 
number. Our findings suggest that clinicians should be aware that the diagnosis of non-
specific chest pain is not always benign and that “rule-out” strategies for this diagnosis may 
not be 100% robust, as potentially preventable readmissions for serious cardiovascular events 
may still occur.  
The ANMCO-SIMEU consensus document published by the European Society of 
Cardiology provided the most recent guidance on in-hospital management of patients with 
chest pain.[9] The document proposes an in-hospital diagnostic pathway that aims to identify 
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patients with a high probability of ACS, identify other diseases of non-coronary origin 
requiring emergency or urgent treatment and assess the likelihood of ACS in patients with 
chest pain with no clear cause and non-diagnostic ECG. It suggests nurse led triage with an 
ECG, physical examination and assessment of vital parameters. This is followed by 
emergency room physical examination, blood tests including troponin, blood gas analysis if 
applicable, and further investigations such as bedside ultrasound and radiological studies 
including chest X-ray, chest angiogram CT or multi-slice coronary CT depending on the 
clinical history. The main focus is to identify coronary ischemia and life-threatening causes 
of chest pain but there is limited guidance on what should be done once these serious causes 
have been excluded.  
The American Heart Association published a scientific statement about testing of low-
risk patients presenting to the ED with chest pain.[10] They suggest that low-risk patients are 
increasingly being managed in chest pain units with accelerated diagnostic protocols 
including serial electrocardiograms and cardiac biomarkers. Patients with negative findings 
usually complete a confirmatory test to exclude ischemia such as an exercise treadmill test or 
cardiac imaging study (rest myocardial perfusion imaging or computed tomography coronary 
angiogram). A negative diagnostic protocol facilitates discharge while a positive finding 
results in admission. While this approach is safe, accurate and cost-effective in low-risk 
patients with chest pain there is no further guidance for patients that are admitted. 
Our study builds on the limited outcomes data for patients diagnosed with non-
specific chest pain following an inpatient admission. A previous literature review of 12 
studies incorporating 24,829 patients found that patients with non-specific chest pain are 
heterogeneous and co-existing coronary heart disease was present in nearly 40% of 
patients.[3] In the current study, 33.5% of patients had known coronary artery disease, 11.1% 
had previous myocardial infarction, 13.5% had previous PCI and 8.0% had previous CABG. 
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Ruddox et al further suggests that the prognosis among these patients is not necessarily 
benign as mortality at 1 year was 3.2% and was highest amongst patients with pre-existing 
coronary artery disease. Readmissions up to 1 year ranged from 14% to 40%.  Unfortunately, 
there are no studies of non-specific chest pain which specifically consider ACS, pulmonary 
embolism or aortic dissection. Our evaluation of serious cardiovascular causes for 
readmissions supports the finding that non-specific chest pain remains a condition that may 
not be benign as 2.8% return with ACS, pulmonary embolism or aortic dissection at 6 
months. 
We have observed a major decline in non-specific chest pain diagnoses among 
inpatients over time and a modest increase in the use of investigations. One explanation for 
the decline may be the rise of the chest pain or observation units in the emergency 
department. These units which were first developed in the United States have been shown to 
be safe and cost effective.[11] They have accelerated diagnostic protocols that allow for rapid 
discharge or admission with suspected ACS.[12] In addition, in the absence of such units, the 
greater use of observation status rather than hospital admission is increasingly common.  
Another explanation may be the introduction of the high-sensitivity troponin assays which 
have facilitated early diagnosis to rule out of myocardial infarction, risk stratification in acute 
cardiac conditions and assist therapeutic monitoring.[13] Regular troponins may be negative 
and patients may be diagnosed with non-specific chest pain while high-sensitivity troponin 
would detect very low levels of troponin and myonecrosis so patients are more likely to 
receive a diagnosis of ACS. This is likely the main reason because the increase in number of 
investigations in the current study is small in absolute terms whilst the decrease in non-
cardiac chest pain patients is more significant. However, on the hospital level, availability of 
the chest pain units and investigations are an important consideration as receiving a test may 
change the primary diagnosis and affect readmission rates. For ACS readmissions, we 
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observe that large hospitals were associated with reduced odds of readmission and that these 
hospitals were more likely to undertake coronary angiography and other investigations in this 
group of patients. However, we show that even if tests are performed, the patients may still 
present within 6 months with a serious cardiovascular event. 
The predictors of readmission for a serious cardiovascular event provide potential 
insight into risk stratification of patients assumed to have non-specific chest pain. Patients 
who appear to have more readmissions for ACS have diabetes and existing coronary heart 
disease. Other variables we identified included anemia, cancer and known pulmonary 
circulatory disorders which were independently associated with pulmonary embolism 
readmission and peripheral vascular disease and hypertension were predictors of aortic 
dissection. Cancer is associated with a hypercoagulable state[14] that is known to increase the 
risk of pulmonary embolism.[15] Hypertension is an established risk factor for aortic 
dissections.[16] These non-modifiable variables should be integrated into assessments and 
risk stratification for patients with non-specific chest pain. 
We recently published work showing that 1 in 12 patients with a diagnosis of non-
specific chest pain have an unplanned readmission within 30-days.[17] This study also found 
that nearly three-quarters of patients who were readmitted was for noncardiac reasons 
(73.4%) and the 3 most common reasons for readmission were neuropsychiatric, 
gastrointestinal and infections.[17] Furthermore, patients who received tests had significantly 
lower unplanned readmission rates (6.1% vs 9.3%).[17] We have built on the findings of our 
previous study by including a longer follow up and including the serious and potentially life-
threatening causes which should ideally be identified as early as possible and treated as 
urgently. We show that the peak rates for these serious complications within one week of 
discharge and the impact is significant as the mortality rate and cost burden is high. We also 
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demonstrate that use of tests has value in reducing the proportion of patients that are 
readmitted for these serious causes but they are not 100% reliable. 
The exact reason why 1.34% of patients who received a coronary angiogram were still 
readmitted with acute coronary syndrome is unclear. One reason may be that patients had 
coronary disease which the operator decided to treat medically and they believed that the 
disease was not significant enough to cause the patient symptoms. This could have 
progressed and developed ACS. The other issue is that no test is 100% perfect and patients 
may have received the test but there is no indicator of the quality of the test. For example, if 
patients had a coronary angiogram and the vessels were poorly visualized or a small diagonal 
or obtuse marginal branch may have been missed. 
Our study has several limitations. The nature of the NRD dataset is such that there is 
no possible linkage between years as the data is composed of five unique datasets 
corresponding to the years 2010 to 2014. We had to apply exclusion criteria of patients 
discharged in the last 6 months of year in order to ensure that patients had 6 months of follow 
up and seasonal effects could not be explored. The current analysis is limited because we do 
not have survival information post discharge and it is possible that patients may have died out 
of hospital and not be captured for readmissions. Another important limitation is that our 
study lacks data on results from investigations such as calcium score from CT coronary 
angiography and both troponin and d-dimer levels from blood results. Also, non-specific 
chest pain, a diagnosis of exclusion has no formal definition, so we expect heterogeneity in 
the care received and receipt of investigations for patients leading up to the final diagnosis 
and discharge. In addition, we lack data in the current dataset about medication use and 
follow up plans for patients once discharged. A major limitation of the current study is that 
we do not have information on emergency department discharges as patients may have 
presented with chest pain and directly discharged without admission to hospital. Therefore, 
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the findings on this study are generalizable to the population with an eventual inpatient 
primary diagnosis of non-specific chest pain. Furthermore, regional difference could not be 
explored and out of hospital deaths could not be captured. Finally, we are not able to consider 
patients who were directly discharged from the emergency department with chest pain that 
were not admitted to hospital. 
Conclusions 
In conclusion, non-specific chest pain as a primary diagnosis for hospital admission 
may not be a benign condition as readmissions for serious cardiovascular events occur in 3% 
of these patients. In our study cohort, we estimate that there are approximately 5,586 ACS 
admissions, 950 pulmonary embolism admissions and 113 aortic dissection admissions after 
admission for non-specific chest pain accounting for approximately $120 million dollars of 
healthcare expenditure. Clinicians should be careful to risk stratify and tailor services to 
better manage patients with non-specific chest pain.  
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Figure Legend 
 
Figure 1: Rates of chest pain admission and unplanned readmission for acute coronary 
syndrome, pulmonary embolism and aortic dissection 
 
 
Table 1: Characteristics of participants 
 
Table 2: Predictors of readmission for acute coronary syndrome, pulmonary embolism and 
aortic dissection 
 
Table 3: Predictors of receiving investigation for acute coronary syndrome, pulmonary 
embolism and aortic dissection 
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Table 1: Characteristics of participants 
Variable No readmission Readmission for 
acute coronary 
syndrome 
Readmission for 
pulmonary embolus 
Readmission for 
aortic dissection 
Age (year) 60.0±14.9 64.4±14.2 61.3±16.2 64.1±15.0 
Female 55.1% 44.9% 55.7% 45.6% 
Weekend admission 25.0% 26.7% 26.1% 23.4% 
Year 
2010 
2011 
2012 
2013 
2014 
 
25.5% 
22.1% 
20.4% 
17.4% 
14.7% 
 
24.2% 
21.1% 
20.3% 
18.3% 
16.3% 
 
22.6% 
21.6% 
19.3% 
19.3% 
17.2% 
 
27.4% 
14.5% 
19.0% 
22.2% 
16.9% 
Primary expected 
payer 
Medicare 
Medicaid 
Private 
Uninsured 
No charge 
Other 
 
 
42.7% 
16.1% 
26.8% 
8.7% 
1.1% 
4.6% 
 
 
59.6% 
17.1% 
13.7% 
5.6% 
0.6% 
3.5% 
 
 
55.3% 
20.4% 
14.7% 
5.9% 
0.5% 
3.2% 
 
 
56.9% 
19.8% 
12.9% 
5.2% 
0.4% 
4.8% 
Median household 
income (percentile)  
0-25th 
26-50th 
51-75th 
76-100th 
 
 
33.5% 
24.7% 
22.6% 
19.2% 
 
 
37.5% 
24.4% 
21.2% 
16.9% 
 
 
37.3% 
26.2% 
21.7% 
14.8% 
 
 
36.6% 
24.0% 
19.9% 
19.5% 
Smoking 30.3% 34.5% 31.5% 39.1% 
Alcohol misuse 4.4% 4.2% 5.8% 4.0% 
Dyslipidemia 50.8% 60.4% 46.1% 48.0% 
Hypertension 69.5% 80.9% 72.0% 85.5% 
Diabetes mellitus 31.0% 48.4% 34.6% 22.6% 
Obesity 16.9% 14.9% 21.1% 13.7% 
Previous heart 
failure 
0.4% 0.9% 0.9% 0.8% 
Coronary artery 
disease 
32.7% 67.1% 37.1% 35.9% 
Previous 
myocardial 
infarction 
10.7% 24.5% 11.9% 12.1% 
Previous PCI 13.0% 32.6% 12.9% 12.1% 
Previous CABG 7.6% 21.9% 7.5% 11.7% 
Valvular heart 
disease 
0.2% 0.4% 0.5% 0.4% 
Atrial fibrillation 8.6% 12.7% 11.2% 16.9% 
Previous stroke or 
TIA 
7.5% 12.0% 10.9% 12.9% 
Peripheral vascular 
disease 
5.0% 11.6% 7.4% 37.5% 
Pulmonary 
circulatory disorder 
0.1% 0.2% 0.6% 0% 
Peptic ulcer disease 0.03% 0.05% 0% 0% 
Chronic lung 
disease 
19.8% 25.7% 28.9% 27.8% 
Renal failure 9.5% 23.4% 15.7% 32.3% 
Liver disease 2.4% 2.5% 2.9% 3.2% 
Hypothyroidism 11.4% 11.7% 12.4% 11.7% 
Fluid and 
electrolyte disorder 
11.7% 13.6% 15.9% 14.9% 
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Anemia 10.2% 17.5% 19.1% 18.6% 
Cancer 1.9% 2.4% 9.0% 2.8% 
Depression 11.4% 12.4% 14.9% 12.9% 
Dementia 3.4% 4.6% 5.6% 4.0% 
Charlson 
comorbidity index 
1.1±1.3 1.9±1.6 1.7±1.7 2.0±1.6 
Hospital-bed 
number 
Small 
Medium 
Large 
 
9.1% 
24.6% 
66.2% 
 
9.7% 
25.3% 
65.0% 
 
8.3% 
25.4% 
66.3% 
 
8.1% 
20.2% 
71.8% 
Urban hospital 7.8% 8.9% 7.9% 4.0% 
Teaching hospital 44.7% 44.8% 47.8% 52.4% 
Coronary 
angiogram 
17.2% 9.3% 15.9% 10.9% 
Echocardiogram 5.8% 5.0% 4.8% 3.2% 
Stress test 6.0% 4.3% 3.9% 5.2% 
CT thorax 1.5% 1.1% 2.7% 4.0% 
MRI 0.02% 0.02% 0% 0% 
Pulmonary scan 0.2% 0.2% 0.5% 0.4% 
Radioisotope scan 2.7% 2.0% 1.8% 3.6% 
Aortogram 1.2% 0.8% 1.0% 1.6% 
Length of stay 
(days) 
1.8±2.2 2.1±2.1 2.5±2.4 2.5±2.6 
Cost of admission 
(USD) 
$5,288±4,876 $5,299±4,303 $6,276±4,661 $6,616±4,600 
Discharge location  
Home 
Transfer to other 
hospital 
Care home 
Discharge against 
medical advice 
 
87.9% 
4.7% 
 
4.1% 
3.3% 
 
78.3% 
8.1% 
 
7.4% 
6.2% 
 
75.9% 
9.7% 
 
9.7% 
4.7% 
 
77.8% 
6.5% 
 
11.3% 
4.4% 
Readmissions outcomes 
Cost of readmission 
(USD) 
- $17,708±23,137 $18,412±30,815 $31,270±48,377 
Readmission length 
of stay (days) 
- 5.4±7.3 8.6±11.4 8.7±12.9 
Readmission death - 5.2% 6.7% 10.9% 
PCI = percutaneous coronary intervention, CABG = coronary artery bypass graft, CT = computed tomography, 
MRI = magnetic resonance imaging, USD = US dollar 
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Table 2: Predictors of readmission for acute coronary syndrome, pulmonary embolism and 
aortic dissection 
Variable Odds ratio for 
readmission with acute 
coronary syndrome 
(95%CI) 
Odds ratio for 
readmission with 
pulmonary embolus 
(95%CI) 
Odds ratio for 
readmission with aortic 
dissection (95%CI) 
Age (year) NS 0.99 (0.99-1.00) NS 
Female 0.82 (0.78-0.86) NS NS 
Weekend admission 1.07 (1.02-1.12) NS NS 
Year vs 2010 
2011 
2012 
2013 
2014 
 
NS 
NS 
NS 
NS 
 
NS 
NS 
NS 
NS 
 
0.55 (0.32-0.95) 
NS 
NS 
NS 
Primary expected payer 
vs Medicare 
Medicaid 
Private 
Uninsured 
No charge 
Other 
 
NS 
0.66 (0.61-0.71) 
0.71 (0.64-0.79) 
0.65 (0.51-0.84) 
0.79 (0.70-0.89) 
 
NS 
0.48 (0.40-0.57) 
0.56 (0.44-0.72) 
0.30 (0.16-0.57) 
0.54 (0.40-0.72) 
 
NS 
0.52 (0.29-0.94) 
NS 
NS 
NS 
Median household 
income (percentile)  vs 0-
25th 
26-50th 
51-75th 
76-100th 
 
0.88 (0.83-0.93) 
0.86 (0.81-0.92) 
0.87 (0.81-0.93) 
 
NS 
NS 
0.82 (0.69-0.96) 
 
NS 
NS 
NS 
Smoking 1.11 (1.06-1.17) NS NS 
Alcohol misuse NS 1.38 (1.11-1.71) NS 
Dyslipidemia NS 0.86 (0.77-0.95) 0.62 (0.43-0.90) 
Hypertension 1.25 (1.17-1.32) NS 1.90 (1.18-3.04) 
Diabetes mellitus 1.49 (1.43-1.57) NS 0.44 (0.29-0.65) 
Obesity 0.87 (0.82-0.93) 1.31 (1.15-1.49) NS 
Previous heart failure NS NS NS 
Coronary artery disease 2.29 (2.15-2.44) NS NS 
Previous myocardial 
infarction 
1.25 (1.19-1.32) NS NS 
Previous PCI 1.65 (1.56-1.75) NS NS 
Previous CABG 1.52 (1.43-1.61) NS NS 
Valvular heart disease NS NS NS 
Atrial fibrillation NS NS NS 
Previous stroke or TIA 1.07 (1.00-1.15) NS NS 
Peripheral vascular 
disease 
1.36 (1.26-1.46) 1.23 (1.00-1.51) 8.63 (5.47-13.60) 
Pulmonary circulatory 
disorder 
NS 2.20 (1.09-4.43) NS 
Peptic ulcer disease NS NS NS 
Chronic lung disease 1.12 (1.06-1.18) 1.29 (1.14-1.43) NS 
Renal failure 1.65 (1.56-1.75) NS 2.08 (1.34-3.24) 
Liver disease NS NS NS 
Hypothyroidism NS NS NS 
Fluid and electrolyte 
disorder 
NS NS NS 
Anemia 1.24 (1.17-1.32) 1.62 (1.40-1.86) NS 
Cancer NS 4.15 (3.43-5.02) NS 
Depression NS 1.20 (1.04-1.40) NS 
Dementia 0.90 (0.80-1.00) NS NS 
Hospital-bed number vs    
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small 
Medium 
Large 
NS 
0.86 (0.80-1.00) 
1.26 (1.02-1.55) 
1.31 (1.09-1.59) 
NS 
NS 
Urban hospital 1.13 (1.05-1.01) NS 0.48 (0.23-1.00) 
Teaching hospital NS 1.14 (1.02-1.27) NS 
Coronary angiogram 0.48 (0.45-0.52) NS NS 
Echocardiogram NS 0.79 (0.63-0.99) 0.43 (0.21-0.87) 
Stress test 0.85 (0.75-0.96) NS NS 
CT thorax 0.81 (0.68-0.98) 1.78 (1.39-2.29) 2.25 (1.22-4.91) 
MRI NS NS NS 
Pulmonary scan NS NS NS 
Radioisotope scan NS NS NS 
Aortogram NS NS NS 
Discharge location vs 
home 
Transfer to other hospital 
Care home 
Discharge against 
medical advice 
 
 
1.34 (1.23-1.46) 
1.29 (1.18-1.40) 
1.94 (1.78-2.12) 
 
 
1.85 (1.52-2.24) 
1.96 (1.62-2.36) 
1.56 (1.21-2.01) 
 
 
NS 
1.98 (1.10-3.56) 
NS 
PCI = percutaneous coronary intervention, CABG = coronary artery bypass graft, CT = computed tomography, 
MRI = magnetic resonance imaging, NS = not statistically significant p>0.05 
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Table 3: Predictors of receiving investigation for acute coronary syndrome, pulmonary 
embolism and aortic dissection 
Variable Coronary angiogram Test for pulmonary 
embolus 
Test for aortic dissection 
Age (year) 0.99 (0.99-0.99) 1.01 (1.00-1.01) 0.99 (0.99-1.00) 
Female NS 1.06 (1.03-1.10) NS 
Weekend admission 0.81 (0.79-0.83) NS NS 
Year vs 2010 
2011 
2012 
2013 
2014 
 
NS 
NS 
NS 
NS 
 
NS 
NS 
NS 
NS 
 
NS 
NS 
NS 
NS 
Primary expected payer 
vs Medicare 
Medicaid 
Private 
Uninsured 
No charge 
Other 
 
 
0.59 (0.56-0.61) 
1.20 (1.16-1.24) 
0.76 (0.72-0.81) 
0.69 (0.59-0.80) 
NS 
 
 
1.35 (1.25-1.47) 
1.16 (1.09-1.23) 
0.81 (0.72-0.91) 
NS 
1.24 (1.05-1.46) 
 
 
NS 
NS 
0.72 (0.65-0.80) 
0.70 (0.51-0.95) 
NS 
Median household 
income (percentile)  vs 0-
25th 
26-50th 
51-75th 
76-100th 
 
 
 
NS 
0.88 (0.83-0.93) 
0.74 (0.68-0.80) 
 
 
 
1.25 (1.12-1.38) 
1.60 (1.41-1.82) 
2.63 (2.20-3.16) 
 
 
 
NS 
NS 
1.53 (1.31-1.80) 
Smoking 1.28 (1.24-1.31) NS NS 
Alcohol misuse 0.65 (0.62-0.69) NS 0.78 (0.70-0.88) 
Dyslipidemia 1.45 (1.41-1.48) NS NS 
Hypertension 1.03 (1.01-1.05) NS NS 
Diabetes mellitus 0.88 (0.86-0.90) 1.05 (1.01-1.10) 0.89 (0.84-0.93) 
Obesity 1.42 (1.38-1.46) 1.15 (1.09-1.21) 1.13 (1.06-1.20) 
Previous heart failure 0.43 (0.35-0.52) NS NS 
Coronary artery disease 2.40 (2.31-2.48) 0.75 (0.70-0.80) 1.31 (1.22-1.41) 
Previous myocardial 
infarction 
0.68 (0.66-0.71) 1.10 (1.04-1.17) 0.78 (0.72-0.85) 
Previous PCI NS 0.86 (0.80-0.91) 0.70 (0.64-0.76) 
Previous CABG 0.48 (0.45-0.50) 0.90 (0.84-0.97) 0.83 (0.76-0.91) 
Valvular heart disease 0.66 (0.51-0.86) NS NS 
Atrial fibrillation 0.96 (0.92-0.99) 0.85 (0.80-0.91) 0.91 (0.84-0.99) 
Previous stroke or TIA 0.87 (0.84-0.90) NS NS 
Peripheral vascular 
disease 
1.13 (1.08-1.17) 1.32 (1.22-1.43) 2.64 (2.44-2.87) 
Pulmonary circulatory 
disorder 
0.62 (0.42-0.92) NS NS 
Peptic ulcer disease NS NS NS 
Chronic lung disease NS NS 1.06 (1.01-1.12) 
Renal failure 0.72 (0.69-0.75) NS 0.59 (0.54-0.65) 
Liver disease NS 1.27 (1.15-1.40) 1.19 (1.05-1.34) 
Hypothyroidism 1.11 (1.07-1.14) 0.93 (0.88-0.98) NS 
Fluid and electrolyte 
disorder 
0.91 (0.88-0.94) 0.89 (0.83-0.94) NS 
Anemia 0.82 (0.79-0.85) 1.09 (1.03-1.16) 0.90 (0.83-0.97) 
Cancer 0.57 (0.52-0.62) 1.34 (1.20-1.49) 1.52 (1.34-1.73) 
Depression NS 0.88 (0.83-0.93) 0.91 (0.85-0.98) 
Dementia 0.37 (0.34-0.41) 0.79 (0.71-0.88) 0.71 (0.62-0.83) 
Hospital-bed number vs 
small 
Medium 
 
1.59 (1.37-1.85) 
2.01 (1.75-2.31) 
 
NS 
1.42 (1.05-1.91) 
 
NS 
1.57 (1.26-1.95) 
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Large 
Urban hospital 0.67 (1.37-1.84) 0.57 (0.43-0.76) NS 
Teaching hospital 1.13 (1.04-1.22) 1.94 (1.58-2.38) 1.57 (1.36-1.83) 
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Highlights (85 words) 
 Cardiovascular (CV) readmissions after admissions for chest pain are unknown. 
 3% of patients with nonspecific chest pain have CV readmission within 6 months.  
 The daily readmissions for CV events appear to peak within a week of discharge.  
 Predictors of readmissions include diabetes and existing coronary artery disease.  
 The cost of these readmissions are ~$120 million dollars between 2010 and 2014. 
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